Digital repository of Slovenian research organisations

Show document
A+ | A- | Help | SLO | ENG

Title:Use of HuH6 and other human-derived hepatoma lines for the detection of genotoxins : a new hope for laboratory animals?
Authors:ID Waldherr, Monika (Author)
ID Mišík, Miroslav (Author)
ID Ferk, Franziska (Author)
ID Tomc, Jana (Author)
ID Žegura, Bojana (Author)
ID Filipič, Metka (Author)
ID Mikulits, Wolfgang (Author)
ID Mai, Sören (Author)
ID Haas, Oskar (Author)
ID Huber, Wolfgang W. (Author)
ID Haslinger, Elisabeth (Author)
ID Knasmüller, Siegfried (Author)
Files:.pdf PDF - Presentation file, download (1,18 MB)
MD5: 00E8479EE05520A76E91C361FB94E9DF
 
URL URL - Source URL, visit https://doi.org/10.1007/s00204-017-2109-4
 
Language:English
Typology:1.01 - Original Scientific Article
Organization:Logo NIB - National Institute of Biology
Abstract:Cell lines which are currently used in genotoxicity tests lack enzymes which activate/detoxify mutagens. Therefore, rodent-derived liver preparations are used which reflect their metabolism in humans only partly; as a consequence misleading results are often obtained. Previous findings suggest that certain liver cell lines express phase I/II enzymes and detect promutagens without activation; however, their use is hampered by different shortcomings. The aim of this study was the identification of a suitable cell line. The sensitivity of twelve hepatic cell lines was investigated in single cell gel electrophoresis assays. Furthermore, characteristics of these lines were studied which are relevant for their use in genotoxicity assays (mitotic activity, p53 status, chromosome number, and stability). Three lines (HuH6, HCC1.2, and HepG2) detected representatives of five classes of promutagens, namely, IQ and PhIP (HAAs), B(a)P (PAH), NDMA (nitrosamine), and AFB1 (aflatoxin), and were sensitive towards reactive oxygen species (ROS). In contrast, the commercially available line HepaRG, postulated to be a surrogate for hepatocytes and an ideal tool for mutagenicity tests, did not detect IQ and was relatively insensitive towards ROS. All other lines failed to detect two or more compounds. HCC1.2 cells have a high and unstable chromosome number and mutated p53, these features distract from its use in routine screening. HepG2 was frequently employed in earlier studies, but pronounced inter-laboratory variations were observed. HuH6 was never used in genotoxicity experiments and is highly promising, it has a stable karyotype and we demonstrated that the results of genotoxicity experiments are reproducible.
Keywords:hepatic cell lines, p53, comet assay, genotoxicity
Publication status:Published
Publication version:Version of Record
Publication date:01.01.2018
Year of publishing:2018
Number of pages:str. 921-934
Numbering:Vol. 92, iss. 2
PID:20.500.12556/DiRROS-19633 New window
UDC:577
ISSN on article:0340-5761
DOI:10.1007/s00204-017-2109-4 New window
COBISS.SI-ID:4521807 New window
Publication date in DiRROS:24.07.2024
Views:309
Downloads:201
Metadata:XML DC-XML DC-RDF
:
Copy citation
  
Share:Bookmark and Share


Hover the mouse pointer over a document title to show the abstract or click on the title to get all document metadata.

Record is a part of a journal

Title:Archives of toxicology
Shortened title:Arch Toxicol
Publisher:Springer
ISSN:0340-5761
COBISS.SI-ID:562452 New window

Document is financed by a project

Funder:ARIS - Slovenian Research and Innovation Agency
Project number:J1-6730-2014
Name:Razvoj novih celičnih linij človeških jeter za raziskave genotoksičnosti in karcinogenosti: novo upanje za človekovo zdravje in zaščito laboratorijskih živali

Funder:FWF - Austrian Science Fund
Project number:I2059-B20

Funder:EC - European Commission
Funding programme:COST Action
Project number:CA15132
Acronym:hCOMET

Licences

License:CC BY 4.0, Creative Commons Attribution 4.0 International
Link:http://creativecommons.org/licenses/by/4.0/
Description:This is the standard Creative Commons license that gives others maximum freedom to do what they want with the work as long as they credit the author.

Back